The Akt inhibitor KP372-1 inhibits proliferation and induces apoptosis and anoikis in squamous cell carcinoma of the head and neck

Mahitosh Mandal, Maher Younes, Eric A. Swan, Samar A. Jasser, Dao Doan, Orhan Yigitbasi, Andrea McMurphey, James Ludwick, Adel K. El-Naggar, Cora Bucana, Gordon Mills, Jeffrey N. Myers

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Therapies that target signaling pathways critical to the pathogenesis and progression of squamous cell carcinoma of the head and neck (HNSCC) are needed. One such target, phosphatidylinositol 3-kinase, and its downstream target serine/threonine kinase, Akt, are up-regulated in HNSCC. Targeted therapy could consist of inhibitors of these kinases or, alternatively, of inhibitors of the pathways that they regulate. To explore the effect of Akt inhibition on the growth and survival of HNSCC tumors, we evaluated the effect of a novel Akt inhibitor, KP372-1, on the growth, survival, and sensitivity to anoikis of HNSCC cell lines in culture. Using Western blotting of head and neck cancer cell lines and squamous mucosa and carcinoma specimens, we found that Akt was highly phosphorylated in head and neck cancer cell lines and human head and neck squamous carcinoma specimens. Treatment of HNSCC cell lines with KP372-1 blocked the activation of Akt, inhibited head and neck cancer cell proliferation, and induced apoptosis and anoikis in several HNSCC cell lines. Furthermore, KP372-1 decreased the phosphorylation of the S6 ribosomal (Ser240/244) protein, which is a downstream target of Akt. Taken together, these findings indicate that KP372-1 may be a useful therapeutic agent for HNSCC and should be further evaluated in preclinical models of HNSCC.

Original languageEnglish (US)
Pages (from-to)430-439
Number of pages10
JournalOral Oncology
Volume42
Issue number4
DOIs
StatePublished - Apr 1 2006
Externally publishedYes

Fingerprint

Anoikis
Apoptosis
Cell Line
Head and Neck Neoplasms
Squamous Cell Carcinoma
Phosphatidylinositol 3-Kinase
S 6
Critical Pathways
Survival
Protein-Serine-Threonine Kinases
Growth
Mucous Membrane
Neck
Phosphotransferases
Therapeutics
Western Blotting
Head
Phosphorylation
Cell Proliferation
Carcinoma, squamous cell of head and neck

Keywords

  • Akt
  • Anoikis
  • Apoptosis
  • KP372-1

ASJC Scopus subject areas

  • Oncology

Cite this

The Akt inhibitor KP372-1 inhibits proliferation and induces apoptosis and anoikis in squamous cell carcinoma of the head and neck. / Mandal, Mahitosh; Younes, Maher; Swan, Eric A.; Jasser, Samar A.; Doan, Dao; Yigitbasi, Orhan; McMurphey, Andrea; Ludwick, James; El-Naggar, Adel K.; Bucana, Cora; Mills, Gordon; Myers, Jeffrey N.

In: Oral Oncology, Vol. 42, No. 4, 01.04.2006, p. 430-439.

Research output: Contribution to journalArticle

Mandal, M, Younes, M, Swan, EA, Jasser, SA, Doan, D, Yigitbasi, O, McMurphey, A, Ludwick, J, El-Naggar, AK, Bucana, C, Mills, G & Myers, JN 2006, 'The Akt inhibitor KP372-1 inhibits proliferation and induces apoptosis and anoikis in squamous cell carcinoma of the head and neck', Oral Oncology, vol. 42, no. 4, pp. 430-439. https://doi.org/10.1016/j.oraloncology.2005.09.011
Mandal, Mahitosh ; Younes, Maher ; Swan, Eric A. ; Jasser, Samar A. ; Doan, Dao ; Yigitbasi, Orhan ; McMurphey, Andrea ; Ludwick, James ; El-Naggar, Adel K. ; Bucana, Cora ; Mills, Gordon ; Myers, Jeffrey N. / The Akt inhibitor KP372-1 inhibits proliferation and induces apoptosis and anoikis in squamous cell carcinoma of the head and neck. In: Oral Oncology. 2006 ; Vol. 42, No. 4. pp. 430-439.
@article{3a29b7e4785f4c059a6d658a8a9a2b93,
title = "The Akt inhibitor KP372-1 inhibits proliferation and induces apoptosis and anoikis in squamous cell carcinoma of the head and neck",
abstract = "Therapies that target signaling pathways critical to the pathogenesis and progression of squamous cell carcinoma of the head and neck (HNSCC) are needed. One such target, phosphatidylinositol 3-kinase, and its downstream target serine/threonine kinase, Akt, are up-regulated in HNSCC. Targeted therapy could consist of inhibitors of these kinases or, alternatively, of inhibitors of the pathways that they regulate. To explore the effect of Akt inhibition on the growth and survival of HNSCC tumors, we evaluated the effect of a novel Akt inhibitor, KP372-1, on the growth, survival, and sensitivity to anoikis of HNSCC cell lines in culture. Using Western blotting of head and neck cancer cell lines and squamous mucosa and carcinoma specimens, we found that Akt was highly phosphorylated in head and neck cancer cell lines and human head and neck squamous carcinoma specimens. Treatment of HNSCC cell lines with KP372-1 blocked the activation of Akt, inhibited head and neck cancer cell proliferation, and induced apoptosis and anoikis in several HNSCC cell lines. Furthermore, KP372-1 decreased the phosphorylation of the S6 ribosomal (Ser240/244) protein, which is a downstream target of Akt. Taken together, these findings indicate that KP372-1 may be a useful therapeutic agent for HNSCC and should be further evaluated in preclinical models of HNSCC.",
keywords = "Akt, Anoikis, Apoptosis, KP372-1",
author = "Mahitosh Mandal and Maher Younes and Swan, {Eric A.} and Jasser, {Samar A.} and Dao Doan and Orhan Yigitbasi and Andrea McMurphey and James Ludwick and El-Naggar, {Adel K.} and Cora Bucana and Gordon Mills and Myers, {Jeffrey N.}",
year = "2006",
month = "4",
day = "1",
doi = "10.1016/j.oraloncology.2005.09.011",
language = "English (US)",
volume = "42",
pages = "430--439",
journal = "Oral Oncology",
issn = "1368-8375",
publisher = "Elsevier Limited",
number = "4",

}

TY - JOUR

T1 - The Akt inhibitor KP372-1 inhibits proliferation and induces apoptosis and anoikis in squamous cell carcinoma of the head and neck

AU - Mandal, Mahitosh

AU - Younes, Maher

AU - Swan, Eric A.

AU - Jasser, Samar A.

AU - Doan, Dao

AU - Yigitbasi, Orhan

AU - McMurphey, Andrea

AU - Ludwick, James

AU - El-Naggar, Adel K.

AU - Bucana, Cora

AU - Mills, Gordon

AU - Myers, Jeffrey N.

PY - 2006/4/1

Y1 - 2006/4/1

N2 - Therapies that target signaling pathways critical to the pathogenesis and progression of squamous cell carcinoma of the head and neck (HNSCC) are needed. One such target, phosphatidylinositol 3-kinase, and its downstream target serine/threonine kinase, Akt, are up-regulated in HNSCC. Targeted therapy could consist of inhibitors of these kinases or, alternatively, of inhibitors of the pathways that they regulate. To explore the effect of Akt inhibition on the growth and survival of HNSCC tumors, we evaluated the effect of a novel Akt inhibitor, KP372-1, on the growth, survival, and sensitivity to anoikis of HNSCC cell lines in culture. Using Western blotting of head and neck cancer cell lines and squamous mucosa and carcinoma specimens, we found that Akt was highly phosphorylated in head and neck cancer cell lines and human head and neck squamous carcinoma specimens. Treatment of HNSCC cell lines with KP372-1 blocked the activation of Akt, inhibited head and neck cancer cell proliferation, and induced apoptosis and anoikis in several HNSCC cell lines. Furthermore, KP372-1 decreased the phosphorylation of the S6 ribosomal (Ser240/244) protein, which is a downstream target of Akt. Taken together, these findings indicate that KP372-1 may be a useful therapeutic agent for HNSCC and should be further evaluated in preclinical models of HNSCC.

AB - Therapies that target signaling pathways critical to the pathogenesis and progression of squamous cell carcinoma of the head and neck (HNSCC) are needed. One such target, phosphatidylinositol 3-kinase, and its downstream target serine/threonine kinase, Akt, are up-regulated in HNSCC. Targeted therapy could consist of inhibitors of these kinases or, alternatively, of inhibitors of the pathways that they regulate. To explore the effect of Akt inhibition on the growth and survival of HNSCC tumors, we evaluated the effect of a novel Akt inhibitor, KP372-1, on the growth, survival, and sensitivity to anoikis of HNSCC cell lines in culture. Using Western blotting of head and neck cancer cell lines and squamous mucosa and carcinoma specimens, we found that Akt was highly phosphorylated in head and neck cancer cell lines and human head and neck squamous carcinoma specimens. Treatment of HNSCC cell lines with KP372-1 blocked the activation of Akt, inhibited head and neck cancer cell proliferation, and induced apoptosis and anoikis in several HNSCC cell lines. Furthermore, KP372-1 decreased the phosphorylation of the S6 ribosomal (Ser240/244) protein, which is a downstream target of Akt. Taken together, these findings indicate that KP372-1 may be a useful therapeutic agent for HNSCC and should be further evaluated in preclinical models of HNSCC.

KW - Akt

KW - Anoikis

KW - Apoptosis

KW - KP372-1

UR - http://www.scopus.com/inward/record.url?scp=33645085614&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645085614&partnerID=8YFLogxK

U2 - 10.1016/j.oraloncology.2005.09.011

DO - 10.1016/j.oraloncology.2005.09.011

M3 - Article

C2 - 16442835

AN - SCOPUS:33645085614

VL - 42

SP - 430

EP - 439

JO - Oral Oncology

JF - Oral Oncology

SN - 1368-8375

IS - 4

ER -